Pseudomonas Infections
Showing 1 - 25 of 7,706
Pseudomonas Aeruginosa Infections Among COVID-19 Intensive Care
Not yet recruiting
- Pseudomonas Aeruginosa
- COVID-19
- Observation
-
Vandœuvre-lès-Nancy, Lorraine, FranceNancy University Hospital
Nov 17, 2023
Modifications to Rendering of Antibiogram on Prescriptions of
Recruiting
- Pseudomonas
-
Strasbourg, FranceService des Maladies Infectieuses et Tropicales - CHU de Strasbo
Oct 30, 2023
Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)
Recruiting
- Bladder Cancer
- Pseudomonas aeruginosa
-
Jinan, Shandong, ChinaQilu hospital
Jul 26, 2023
Efflux Pump and Virulence Factors Genes in Pseudomonas
Not yet recruiting
- Pseudomonas Aeruginosa
- culture on cetrimide agar
- +3 more
- (no location specified)
Nov 29, 2022
During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia
Completed
- Pseudomonas Aeruginosa
- Ventilation Acquired Pneumonia
-
Grenoble, Isère, FranceMedical ICU of Universitary Hospital of Grenoble
Nov 7, 2022
Toxins in Lung Infections Caused by Pseudomonas Aeruginosa
Completed
- Pseudomonas Infection
- Cystic Fibrosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 3, 2022
Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection Trial in Farmington, Tyler (AP-PA02, Placebo)
Recruiting
- Non-cystic Fibrosis Bronchiectasis
- +2 more
- AP-PA02
- Placebo
-
Farmington, Connecticut
- +1 more
Jan 13, 2023
Isolation of Human Recombinant Therapeutic Monoclonal
Recruiting
- Pseudomonas Aeruginosa
- Multi-antibiotic Resistance
- Isolation of anti-Pseudomonas antibodies from type B lymphocytes
-
Grenoble, FranceChu Grenoble Alpes
May 6, 2022
Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
Recruiting
- Pseudomonas Aeruginosa
- +2 more
-
Jakarta, Indonesia
- +2 more
Mar 22, 2022
Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa
Active, not recruiting
- Antibiotic Resistant Strain
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Mar 30, 2022
Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis Trial in Israel, United States (BX004-A, Placebo)
Recruiting
- Chronic Pseudomonas Aeruginosa Infection
- Cystic Fibrosis
- BX004-A
- Placebo
-
Hollywood, Florida
- +7 more
Jun 28, 2022
Pseudomonas Aeruginosa, Pneumonia, Hematologic Malignancy Trial in New York (Ceftolozane / Tazobactam Injection)
Suspended
- Pseudomonas Aeruginosa
- +2 more
- Ceftolozane / Tazobactam Injection
-
New York, New YorkWeill Cornell Medicine
Jan 25, 2022
Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas Trial in United States (AP-PA02, Placebo)
Active, not recruiting
- Cystic Fibrosis
- +4 more
- AP-PA02
- Placebo
-
Los Angeles, California
- +19 more
Dec 20, 2022
Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection Trial in Jerusalem, Tel Aviv (TP-102)
Recruiting
- Diabetic Foot Ulcer
- +3 more
- TP-102
-
Jerusalem, Israel
- +1 more
Jun 17, 2022
Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa Trial in Australia, United States
Not yet recruiting
- Cystic Fibrosis Lung
- +2 more
- RSP-1502
- Tobramycin inhalation solution
-
Tucson, Arizona
- +14 more
Aug 24, 2023
Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection Trial (Rapid Diagnostics)
Not yet recruiting
- Blood Stream Infections
- +4 more
- Rapid Diagnostics
- (no location specified)
Jul 31, 2023
Covid19, Bacteremia, Septicemia Trial (Phage Therapy)
No longer available
- Covid19
- +5 more
- Phage Therapy
- (no location specified)
Dec 6, 2021
Patients With Infection by Resistant Microorganism
Enrolling by invitation
- Pneumonia
- +10 more
- Pathogen resistant phenotype
-
Sevilla, SpainHospital Universitario Virgen Macarena
May 18, 2023
Tracheostomy Infection Trial in Oakland (Inhaled Aztreonam)
Terminated
- Tracheostomy Infection
- Inhaled Aztreonam
-
Oakland, CaliforniaBenioff Children's Hospital Oakland
Jul 9, 2021
Bacterial Disease Carrier, Cystic Fibrosis Trial in United States (Placebo, WRAIR_PAM-CF1)
Recruiting
- Bacterial Disease Carrier
- Cystic Fibrosis
- Placebo
- WRAIR_PAM-CF1
-
La Jolla, California
- +14 more
Aug 11, 2022
Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)
Not yet recruiting
- Bronchiectasis
- +3 more
- (no location specified)
Sep 6, 2023
Ventilator-Associated Pneumonia Trial in Paris (8 days of effective antibiotic treatment, 15 days of effective antibiotic
Completed
- Ventilator-Associated Pneumonia
- 8 days of effective antibiotic treatment
- 15 days of effective antibiotic treatment
-
Paris, FranceAnesthesiology and Critical Care Medicine Institut de Cardiologi
Oct 15, 2021
Trikafta/Kaftrio and Pseudomonas Aeruginosa
Recruiting
- Cystic Fibrosis
-
Milan, Italy
- +1 more
Jan 9, 2023
Resistance in Carbapenemase-producing Enterobacterales and
Enrolling by invitation
- Bacterial Infections
- Antibiotic Resistant Infection
- No intervention
-
Rio De Janeiro, BrazilD'Or Institute for Research and Education (IDOR)
Mar 16, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022